N-(5-(sec-butylthio)-1,3,4-thiadiazol-2-yl)-2-(trifluoromethyl)benzamide structure
|
Common Name | N-(5-(sec-butylthio)-1,3,4-thiadiazol-2-yl)-2-(trifluoromethyl)benzamide | ||
|---|---|---|---|---|
| CAS Number | 391875-45-9 | Molecular Weight | 361.4 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C14H14F3N3OS2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
| Name | N-(5-(sec-butylthio)-1,3,4-thiadiazol-2-yl)-2-(trifluoromethyl)benzamide |
|---|
| Molecular Formula | C14H14F3N3OS2 |
|---|---|
| Molecular Weight | 361.4 |
| InChIKey | DEAVYRXCNSSHPG-UHFFFAOYSA-N |
| SMILES | CCC(C)SC1=NN=C(S1)NC(=O)C2=CC=CC=C2C(F)(F)F |
|
Name: Discovery of Small Molecules to Inhibit Human Cytomegalovirus Nuclear Egress
Source: ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
Target: HCMV UL50
External Id: HMS1262
|